{"title":"Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme","link":"https://arstechnica.com/?p=2034747","date":1719857810000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2024/07/GettyImages-1236271712-800x533.jpeg\" alt=\"Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2024/07/GettyImages-1236271712-scaled.jpeg\">Enlarge</a> (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/in-this-photo-illustration-a-cassava-sciences-inc-logo-is-news-photo/1236271712?searchscope=image%2Cfilm&amp;adppopup=true\">Getty | Pavlo Gonchar</a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>A federal grand jury has indicted an embattled Alzheimer's researcher for <a href=\"https://www.justice.gov/opa/pr/professor-charged-operating-multimillion-dollar-grant-fraud-scheme\">allegedly falsifying data to fraudulently obtain $16 million in federal research funding</a> from the National Institutes of Health for the development of a controversial Alzheimer's drug and diagnostic test.</p>\n<p>Hoau-Yan Wang, 67, a medical professor at the City University of New York, was a paid collaborator with the Austin, Texas-based pharmaceutical company Cassava Sciences. Wang's research and publications provided scientific underpinnings for Cassava's Alzheimer's treatment, Simufilam, which is <a href=\"https://clinicaltrials.gov/study/NCT05026177?term=Simufilam&amp;aggFilters=phase:3&amp;rank=2\">now in</a> Phase III <a href=\"https://clinicaltrials.gov/study/NCT04994483?term=Simufilam&amp;aggFilters=phase:3&amp;rank=3\">trials</a>.</p>\n<p>Simufilam is a small-molecule drug that Cassava claims can restore the structure and function of a scaffolding protein in the brain of people with Alzheimer's, leading to slowed cognitive decline. But outside researchers have long expressed doubts and concerns about the research.</p></div><p><a href=\"https://arstechnica.com/?p=2034747#p3\">Read 7 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=2034747&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"3b7824774bc5b35a356dc18c3d0c048877ba6d37cba2e8e07e8ff44e10d18dd2","category":"Tech"}